Neothetics Announces Leadership Change and Preliminary Update on LIPO-202
February 18, 2016 16:00 ET | Neothetics, Inc.
SAN DIEGO, Feb. 18, 2016 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced...
Neothetics to Present at the 27th Annual Roth Conference
March 04, 2015 08:00 ET | Neothetics, Inc.
SAN DIEGO, March 4, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced that...